Trinity Biotech Plc Total Revenue

As of the most recent data (December 2025), TRIB shows a total revenue of $44M. That compares with $62M in the prior-year period — down 28.8% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TRIB's total revenue is now $44M (was $62M) — a 28.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Trinity Biotech Plc is outperforming or lagging.

The Healthcare sector average total revenue is about $110B. Trinity Biotech Plc is at $44M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how TRIB stacks up against individual peers as well.

Tracking TRIB's total revenue over time shows whether Trinity Biotech Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $44M That compares with $62M in the prior-year period — down 28.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total revenue page, Stockcircle has Trinity Biotech Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $44M) with ownership activity and broader fundamentals.